blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1344533

EP1344533 - Pharmaceutical compositions comprising mannose binding lectin [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.06.2007
Database last updated on 02.09.2024
Most recent event   Tooltip15.11.2013Lapse of the patent in a contracting statepublished on 18.12.2013  [2013/51]
Applicant(s)For all designated states
Natimmune A/S
Fruebjergvej 3
2100 Kobenhavn 0 / DK
[2003/38]
Inventor(s)01 / Larsen, Jesper Lund
Nrd. Frihavnsgade 100B
2100 Copenhagen / DK
02 / Kongerslev, Leif
Biskop Svanes Vej 39
3460 Birkerod / DK
 [2003/38]
Representative(s)Høiberg, Susanne, et al
Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[N/P]
Former [2003/38]Hoeiberg, Susanne, et al
Hoeiberg ApS, St. Kongensgade 59 B
1264 Copenhagen K / DK
Application number, filing date03388016.214.03.2003
[2003/38]
Priority number, dateDK2002000041415.03.2002         Original published format: DK 200200414
[2003/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1344533
Date:17.09.2003
Language:EN
[2003/38]
Type: B1 Patent specification 
No.:EP1344533
Date:23.08.2006
Language:EN
[2006/34]
Search report(s)(Supplementary) European search report - dispatched on:EP07.07.2003
ClassificationIPC:A61K38/17, A61K38/48, A61P31/00, // (A61K38/48, 38:17)
[2003/38]
CPC:
A61K38/1709 (EP,US); A61K38/482 (EP,US); A61P31/00 (EP);
A61P31/04 (EP); A61P31/10 (EP); A61P31/12 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2003/38]
Extension statesAL17.03.2004
LT17.03.2004
LV17.03.2004
MK17.03.2004
TitleGerman:Mannose-Bindungsprotein enthaltende pharmazeutische Zusammensetzungen[2006/10]
English:Pharmaceutical compositions comprising mannose binding lectin[2003/38]
French:Compositions pharmaceutique comprenant une lectine liant le mannose[2006/10]
Former [2003/38]Mannose-Bindungsprotein enthaltende pharmazeutische Zusammensetzung
Former [2003/38]Composition pharmaceutique comprenant une lectine liant le mannose
Examination procedure08.04.2003Examination requested  [2003/38]
11.11.2003Despatch of a communication from the examining division (Time limit: M04)
11.03.2004Reply to a communication from the examining division
21.07.2004Despatch of a communication from the examining division (Time limit: M06)
14.01.2005Reply to a communication from the examining division
18.02.2005Observations by third parties
18.08.2005Despatch of a communication from the examining division (Time limit: M04)
13.12.2005Reply to a communication from the examining division
17.02.2006Communication of intention to grant the patent
27.06.2006Fee for grant paid
27.06.2006Fee for publishing/printing paid
Opposition(s)24.05.2007No opposition filed within time limit [2007/31]
Fees paidRenewal fee
31.03.2005Renewal fee patent year 03
31.03.2006Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY23.08.2006
CZ23.08.2006
EE23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
TR23.08.2006
BG23.11.2006
GR24.11.2006
HU24.02.2007
IE14.03.2007
LU14.03.2007
MC31.03.2007
[2013/51]
Former [2011/32]CY23.08.2006
CZ23.08.2006
EE23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
TR23.08.2006
BG23.11.2006
GR24.11.2006
HU24.02.2007
IE14.03.2007
LU14.03.2007
MC31.03.2007
Former [2009/43]CY23.08.2006
CZ23.08.2006
EE23.08.2006
IT23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
TR23.08.2006
BG23.11.2006
GR24.11.2006
HU24.02.2007
IE14.03.2007
LU14.03.2007
MC31.03.2007
Former [2009/38]CY23.08.2006
CZ23.08.2006
EE23.08.2006
IT23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
BG23.11.2006
GR24.11.2006
IE14.03.2007
LU14.03.2007
MC31.03.2007
Former [2008/38]CZ23.08.2006
EE23.08.2006
IT23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
BG23.11.2006
GR24.11.2006
IE14.03.2007
MC31.03.2007
Former [2008/21]CZ23.08.2006
IT23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
BG23.11.2006
GR24.11.2006
IE14.03.2007
MC31.03.2007
Former [2008/10]CZ23.08.2006
IT23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
BG23.11.2006
IE14.03.2007
MC31.03.2007
Former [2008/09]CZ23.08.2006
IT23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
BG23.11.2006
MC31.03.2007
Former [2007/41]CZ23.08.2006
IT23.08.2006
RO23.08.2006
SI23.08.2006
SK23.08.2006
BG23.11.2006
Former [2007/40]CZ23.08.2006
IT23.08.2006
SI23.08.2006
SK23.08.2006
BG23.11.2006
Former [2007/28]CZ23.08.2006
SI23.08.2006
SK23.08.2006
BG23.11.2006
Former [2007/22]CZ23.08.2006
SI23.08.2006
BG23.11.2006
Former [2007/13]SI23.08.2006
BG23.11.2006
Documents cited:Search[XY]WO9964453  (STATENS SERUMINSTITUT [DK], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.